| 标题 |
A multicenter, double-blind, placebo-controlled pH3 study of ustekinumab, a human monoclonal antibody to IL-12/23p40, in patients with moderately-severely active Crohn's disease who are not naive or not refractory to anti-TNFa: UNITI-2
一项针对IL-12/23p40的人源单克隆抗体ustekinumab在未初治或抗TNFa难治的中重度活动性克罗恩病患者中的多中心、双盲、安慰剂对照pH3研究：UNITI-2
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 其它 | Feagan B, Gasink C, Lang Y, Friedman JR, Johanns J, Gao LL. A multicenter, double-blind, placebo-controlled pH3 study of ustekinumab, a human monoclonal antibody to IL-12/23p40, in patients with moderately-severely active Crohn's disease who are not naive or not refractory to anti-TNFa: UNITI-2. United European Gastroenterology Journal 2015;3(6):563-4. |
| 求助人 | |
| 下载 | 暂无链接，等待应助者上传 |
从容芮
可千万不要躺平呀
Ivy
wangrblzu
OCDer
nenoaowu
AireenBeryl531
孙燕
zho
Whim
MchemG
VV小蛋糕
遇上就这样吧
blue
雪梅
SYLH
jyy
勤奋白凝
scm
HHHC
皖公网安备34019202002308
